111 related articles for article (PubMed ID: 28865960)
21. Quantitative proteomics of caveolin-1-regulated proteins: characterization of polymerase i and transcript release factor/CAVIN-1 IN endothelial cells.
Dávalos A; Fernández-Hernando C; Sowa G; Derakhshan B; Lin MI; Lee JY; Zhao H; Luo R; Colangelo C; Sessa WC
Mol Cell Proteomics; 2010 Oct; 9(10):2109-24. PubMed ID: 20585024
[TBL] [Abstract][Full Text] [Related]
22. Dedifferentiated liposarcoma of the pyriform sinus: report of a case and review of the literature.
González-Lois C; Ibarrola C; Ballestín C; Martánez-Tello FJ
Int J Surg Pathol; 2002 Jan; 10(1):75-9. PubMed ID: 11927975
[TBL] [Abstract][Full Text] [Related]
23. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
24. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases.
Sioletic S; Dal Cin P; Fletcher CD; Hornick JL
Histopathology; 2013 Jan; 62(2):287-93. PubMed ID: 23020289
[TBL] [Abstract][Full Text] [Related]
25. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
[TBL] [Abstract][Full Text] [Related]
26. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.
Liu L; Brown D; McKee M; Lebrasseur NK; Yang D; Albrecht KH; Ravid K; Pilch PF
Cell Metab; 2008 Oct; 8(4):310-7. PubMed ID: 18840361
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol depletion in adipocytes causes caveolae collapse concomitant with proteosomal degradation of cavin-2 in a switch-like fashion.
Breen MR; Camps M; Carvalho-Simoes F; Zorzano A; Pilch PF
PLoS One; 2012; 7(4):e34516. PubMed ID: 22493697
[TBL] [Abstract][Full Text] [Related]
28. [Pathological significance of NY-ESO-1 expression in the diagnosis of myxoid liposarcoma].
Hei SM; Wei HJ; Chen H; Wang JG
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):225-230. PubMed ID: 30831650
[No Abstract] [Full Text] [Related]
29. Cavin Family: New Players in the Biology of Caveolae.
Nassar ZD; Parat MO
Int Rev Cell Mol Biol; 2015; 320():235-305. PubMed ID: 26614875
[TBL] [Abstract][Full Text] [Related]
30. Cavin-3 knockout mice show that cavin-3 is not essential for caveolae formation, for maintenance of body composition, or for glucose tolerance.
Liu L; Hansen CG; Honeyman BJ; Nichols BJ; Pilch PF
PLoS One; 2014; 9(7):e102935. PubMed ID: 25036884
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
32. Dedifferentiated Liposarcoma With Myofibroblastic Differentiation.
Wang GY; Lucas DR
Arch Pathol Lab Med; 2018 Oct; 142(10):1159-1163. PubMed ID: 30281365
[TBL] [Abstract][Full Text] [Related]
33. Calretinin expression in tumors of adipose tissue.
Cates JM; Coffing BN; Harris BT; Black CC
Hum Pathol; 2006 Mar; 37(3):312-21. PubMed ID: 16613326
[TBL] [Abstract][Full Text] [Related]
34. HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance.
Loria R; Laquintana V; Bon G; Trisciuoglio D; Frapolli R; Covello R; Amoreo CA; Ferraresi V; Zoccali C; Novello M; Del Bufalo D; Milella M; Biagini R; D'Incalci M; Falcioni R
Oncogene; 2018 Nov; 37(45):5926-5938. PubMed ID: 29980789
[TBL] [Abstract][Full Text] [Related]
35. Identification of intracellular cavin target proteins reveals cavin-PP1alpha interactions regulate apoptosis.
McMahon KA; Wu Y; Gambin Y; Sierecki E; Tillu VA; Hall T; Martel N; Okano S; Moradi SV; Ruelcke JE; Ferguson C; Yap AS; Alexandrov K; Hill MM; Parton RG
Nat Commun; 2019 Jul; 10(1):3279. PubMed ID: 31332168
[TBL] [Abstract][Full Text] [Related]
36. Perilipin 1 is a highly specific marker for adipocytic differentiation in sarcomas with intermediate sensitivity.
Westhoff CC; Mrozinski J; Riedel I; Heid HW; Moll R
J Cancer Res Clin Oncol; 2017 Feb; 143(2):225-232. PubMed ID: 27646609
[TBL] [Abstract][Full Text] [Related]
37. Extensive survey of STAT6 expression in a large series of mesenchymal tumors.
Demicco EG; Harms PW; Patel RM; Smith SC; Ingram D; Torres K; Carskadon SL; Camelo-Piragua S; McHugh JB; Siddiqui J; Palanisamy N; Lucas DR; Lazar AJ; Wang WL
Am J Clin Pathol; 2015 May; 143(5):672-82. PubMed ID: 25873501
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
[TBL] [Abstract][Full Text] [Related]
39. Structural insights into the organization of the cavin membrane coat complex.
Kovtun O; Tillu VA; Jung W; Leneva N; Ariotti N; Chaudhary N; Mandyam RA; Ferguson C; Morgan GP; Johnston WA; Harrop SJ; Alexandrov K; Parton RG; Collins BM
Dev Cell; 2014 Nov; 31(4):405-19. PubMed ID: 25453557
[TBL] [Abstract][Full Text] [Related]
40. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]